Related references
Note: Only part of the references are listed.Evolutionary Dynamics of Complex Networks of HIV Drug-Resistant Strains: The Case of San Francisco
Robert J. Smith et al.
SCIENCE (2010)
Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection
J. Gerardo Garcia-Lerma et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Preexposure Antiretroviral Prophylaxis Attitudes in High-Risk Boston Area Men Who Report Having Sex With Men: Limited Knowledge and Experience but Potential for Increased Utilization After Education
Matthew J. Mimiaga et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Phospholipase D in the human ocular surface and in pterygium
Louis Tong et al.
CORNEA (2008)
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course
Nicole Prada et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States
S. M. Owen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir
J. Gerardo Garcia-Lerma et al.
PLOS MEDICINE (2008)
Changes in prevalence of HIV infection and sexual risk behavior in men who have sex with men in San Francisco: 1997-2002
Dennis H. Osmond et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2007)
How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?
Steven D. Pinkerton
AIDS (2007)
Pre-exposure prophylaxis for HIV infection: what if it works?
Lynn A. Paxton et al.
LANCET (2007)
Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection
Clare L. Booth et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection
Susan H. Eshleman et al.
AIDS (2007)
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges
Shambavi Subbarao et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor
RS Veazey et al.
NATURE MEDICINE (2005)
Stability of transmitted drug-resistant HIV-1 species
PA Cane
CURRENT OPINION IN INFECTIOUS DISEASES (2005)
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda
MJ Wawer et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Long-term persistence of primary genotypic resistance after HIV-1 seroconversion
D Pao et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men
M Xiridou et al.
AIDS (2004)
Changing transmission fitness of drug-resistant human immunodeficiency virus against a background of evolving antiretroviral therapy
JM Murray
JOURNAL OF INFECTIOUS DISEASES (2003)
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection
EW Fiebig et al.
AIDS (2003)
Antiretroviral-drug resistance among patients recently infected with HIV
SJ Little et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection
BG Brenner et al.
JOURNAL OF VIROLOGY (2002)
Viral load and heterosexual transmission of human immunodeficiency virus type 1
TC Quinn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA
KKA Van Rompay et al.
JOURNAL OF VIROLOGY (2000)
A tale of two futures: HIV and antiretroviral therapy in San Francisco
SM Blower et al.
SCIENCE (2000)
Share Paper
